Return to homepagePandemic Pact

Targeting ageing in COVID-19 patients to prevent respiratory failure

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $297,936.16

  • Funder

    UFM Denmark

  • Principal Investigator

    Associate Professor Morten Scheibye-Knudsen

  • Research Location

    Denmark

  • Lead Research Institution

    Center for Healthy Aging, Dpt. of Cellular and Molecular Medicine, University of Copenhagen

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older), Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The mortality rate of 80-year- old COVID-19 patients is about 100 times greater than that of a 30-year-old patients. This project will treat older patients with a substance similar to vitamin B and Will investigate what factors make elderly people vulnerable to COVID-19. All in all, the project may lead to a possible treatment of COVID- 19 and an understanding of why elderly people are so particularly vulnerable to this virus.